A revolutionary drug , retatrutide, is generating considerable buzz within the Oz weight management community. Developed by Lilly , this dual GIP and GLP-1 receiver appears to provide more impressive results than current therapies. Preliminary scientific research have shown remarkable decreases in body mass, raising the potential for a different me